PATHEON PROFITS FALL TO US$3M FROM US$3.8M AS DRUG MAKER PLANS EFFICIENCY DRIVE

Drug manufacturer Patheon Inc. reported lower second quarter profits but higher revenues Friday and said it plans an efficiency drive to cut costs and improve the company's bottom line.

Canadian Business Online (http://www.canadianbusiness.com/markets/headline_news/article.jsp?content=b06029A)